News

Cell TherapiesR&D project spotlight: A collaborative approach to developing a universal ddPCR™ assay to detect residual pluripotent stem cells in cell therapy products
Filter:AllPress ReleaseCell TherapiesGene TherapiesDigital and AutomationSpin-outs, Start-ups, Sector investmentManufacturingRegulatory affairsSkills and Training
Year:All2026202520242023 →
CGT Catapult launches commercial readiness advice clinics programme to help cell and gene therapy SMEs and spin-out companies accelerate towards commercialisationCGT Catapult launches commercial readiness advice clinics programme to help cell and gene therapy SMEs and spin-out companies accelerate towards commercialisationRegulatory news - October 2019Regulatory news - October 2019Regulatory news - September 2019Regulatory news - September 2019Cell and Gene Therapy Catapult CEO to RetireCell and Gene Therapy Catapult CEO to RetirePress release: Construction completed on expansion phase, doubling capacity of Cell and Gene Therapy Catapult large scale manufacturing centre in StevenagePress release: Construction completed on expansion phase, doubling capacity of Cell and Gene Therapy Catapult large scale manufacturing centre in StevenageAugust news: Where will we see you this autumn?August news: Where will we see you this autumn?July news: Developing novel reimbursement practicesJuly news: Developing novel reimbursement practicesJune news: Supporting development of cell and gene therapiesJune news: Supporting development of cell and gene therapiesThe Duke of York visits the Cell and Gene Therapy CatapultThe Duke of York visits the Cell and Gene Therapy CatapultRegulatory news - August 2019Regulatory news - August 2019What are the hurdles impacting patient access to cell and gene therapies in the UK?What are the hurdles impacting patient access to cell and gene therapies in the UK?Regulatory news - July 2019Regulatory news - July 2019